relev intrins sympathomimet activ beta blocker intrins sympathomimet activ isa group beta blocker abl beta-adrenerg receptor agonist effect stimul effect catecholamin antagonist effect competit way partial agonist submaxim respons bound receptor maxim occup isol rat atrium acebutolol maxim stimulatori effect maxim effect full beta agonist isoproterenol presenc isa result rest bradycardia reduct cardiac output beta blocker isa long term partial beta agonist arteri vasodil arteri complianc addit benefici effect treatment hypertens beta blocker isa advers effect plasma lipoprotein long-term treatment addit presenc isa up-regul beta adrenoceptor beta blocker isa presenc isa conflict issu use beta blocker secondari prevent myocardi infarct impress result acebutolol prevent secondari infarct trial high-risk patient myocardi infarct show acebutolol beta blocker moder partial agonist activ effect postinfarct mortal rate differ hemodynam profil beta blocker isa partial beta agonist intrigu pharmacolog class drug prospect clinic trial 